GPT Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050
GPT Healthcare Ltd. runs hospitals and provides medical services in India. It was founded in 1989 and is based in Kolkata. Under the ILS brand, it operates four multi-specialty hospitals: Salt Lake, Agartala, Dum Dum, and Howrah. These hospitals have 561 beds, 90 full-time consultants, and 560 visiting doctors. The company offers secondary and tertiary healthcare services.
This blog will provide the details of GPT Healthcare Share Price targets as far as 25 years from now (2025 – 2050) based on its fundamentals, market position, and growth potential.
What is GPT Healthcare Ltd NSE: GPTHEALTH?
GPT Healthcare is expanding its services by opening a new cancer care department in Agartala, which will be Tripura’s first radiation oncology center. It follows an asset-light model to set up hospitals, with a 160-bed Raipur facility. The company plans to expand into Tier II cities like Uttar Pradesh, Assam, and Odisha. It will also introduce orthopedic robotic surgeries in Howrah and a 3D imaging system for neurological cases in Dum Dum. Digital services include the ILS-MyHealth app for patient records and an HMIS system for medical data management.
Fundamental Data
| Metric | Value |
|---|---|
| Market Cap | ₹1,119 Cr. |
| 52-Week High / Low | ₹208 / ₹126 |
| Stock P/E | 22.4 |
| Book Value | ₹28.2 |
| Dividend Yield | 1.83% |
| ROCE (Return on Capital Employed) | 30.3% |
| ROE (Return on Equity) | 24.9% |
| Face Value | ₹10.0 |
| Industry P/E | 53.8 |
| EPS (Earnings Per Share) | ₹6.08 |
| Promoter Holding | 65.6% |
| Net Profit (FY24) | ₹49.8 Cr. |
| Debt | ₹27.9 Cr. |
| Debt to Equity Ratio | 0.12 |
| PBT (Profit Before Tax) Ann. | ₹68.0 Cr. |
| Price to Book Value | 4.84 |
| Graham Number | ₹62.0 |
| Dividend Paid Last Year | ₹28.7 Cr. |
| Current Liabilities | ₹63.7 Cr. |
| Current Assets | ₹69.8 Cr. |
Peer Comparisons
| Company Name | P/E Ratio | Market Cap (₹ Cr.) | Dividend Yield (%) | Net Profit (₹ Cr.) | Quarterly Profit Change (%) | Quarterly Sales (₹ Cr.) | Quarterly Sales Growth (%) | ROCE (%) |
|---|---|---|---|---|---|---|---|---|
| Max Healthcare | 90.83 | 96,310.11 | 0.15 | 238.80 | 0.48 | 1,868.31 | 39.95 | 16.00 |
| Apollo Hospitals | 67.01 | 87,789.88 | 0.26 | 379.40 | 51.77 | 5,526.90 | 13.94 | 15.11 |
| Fortis Health. | 58.14 | 45,708.94 | 0.17 | 254.30 | 76.38 | 1,928.26 | 14.80 | 10.34 |
| Global Health | 62.37 | 31,640.94 | 0.00 | 142.86 | 15.64 | 943.44 | 12.79 | 19.32 |
| Narayana Hrudaya | 40.22 | 31,515.50 | 0.26 | 193.06 | 2.62 | 1,366.68 | 13.55 | 26.54 |
| Krishna Institu. | 65.57 | 22,829.93 | 0.00 | 92.50 | 23.47 | 772.40 | 27.49 | 16.87 |
| Poly Medicure | 71.21 | 22,436.05 | 0.14 | 85.23 | 31.08 | 424.21 | 24.91 | 23.62 |
| GPT Healthcare | 22.45 | 1,118.98 | 1.83 | 12.25 | 6.80 | 102.21 | 5.82 | 30.31 |
| Period | Share Price (INR) |
|---|---|
| Before 1 Year | ₹149 |
| Before 6 Months | ₹190 |
| All-Time Max | ₹208 |
GPT Healthcare Ltd. runs hospitals that provide top medical care in India. With four big hospitals and plans to expand in Raipur, Assam, and Odisha, the business looks strong. Adding cancer care, robotic surgeries, and digital health apps will boost profits. The price may fluctuate tomorrow, but the long-term growth potential remains strong as demand for quality healthcare keeps growing.
| Day | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| Tomorrow | -5.6 from today’s price | +8 from today’s price |
GPTHEALTH Indicator Based Technical Analysis
NOTE!
Signals may differ across timeframes. If you’re planning to purchase GPTHEALTH and keep it for more than one week, it’s suggested that you choose signals from weekly and daily timeframes. For trading in the short term, signals that range from 5 minutes to 1-hour timeframes are better appropriate.
GPT Healthcare is a fast-growing hospital chain in Eastern India, operating four multi-specialty hospitals under the ILS brand. The company has 561 beds, experienced doctors, and advanced medical facilities. As the company expands into new regions and upgrades its services, it is expected to grow strongly. In 2025, the company focuses on broadening patient care by launching a cancer care center in Agartala, the first of its kind in Tripura. This move will help attract more patients and increase revenue.
Our analysis shows that the share price is expected to be between Rs 105 and Rs 195.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2025 | 105 | 195 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| January | 120 | 155 |
| February | 110 | 150 |
| March | 108 | 152 |
| April | 107 | 160 |
| May | 105 | 165 |
| June | 110 | 170 |
| July | 115 | 175 |
| August | 120 | 180 |
| September | 130 | 185 |
| October | 140 | 190 |
| November | 145 | 192 |
| December | 150 | 195 |
By 2026, GPT Healthcare plans to expand into Tier II cities like Uttar Pradesh, Assam, and Odisha. The company also introduces robotic surgeries in Howrah and 3D imaging for neurology in Dum Dum. These advancements will bring in more patients, especially those seeking specialized treatments. Expanding digital services like the ILS-MyHealth app will make healthcare more accessible, improving patient engagement and hospital efficiency.
Our analysis shows that the share price is expected to be between Rs 150 and Rs 275.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2026 | 150 | 275 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| January | 160 | 210 |
| February | 155 | 205 |
| March | 150 | 215 |
| April | 155 | 220 |
| May | 160 | 225 |
| June | 165 | 235 |
| July | 170 | 240 |
| August | 180 | 250 |
| September | 190 | 260 |
| October | 200 | 265 |
| November | 210 | 270 |
| December | 220 | 275 |
In the long term, by 2030, GPT Healthcare aims to strengthen its position in India’s healthcare sector. The company is adopting an asset-light model for new hospitals, which means it will not invest in land and buildings but will operate hospitals through partnerships. The demand for medical tourism from Bangladesh, Nepal, and Bhutan is also expected to boost revenue. The company is set for steady growth with digital healthcare services and high-quality treatments.
Our analysis shows that the share price is expected to be between Rs 750 and Rs 1050.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2030 | 750 | 1050 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| January | 750 | 820 |
| February | 760 | 840 |
| March | 770 | 860 |
| April | 780 | 880 |
| May | 790 | 900 |
| June | 810 | 920 |
| July | 830 | 940 |
| August | 850 | 960 |
| September | 870 | 980 |
| October | 890 | 1000 |
| November | 920 | 1025 |
| December | 950 | 1050 |
In 2040, GPT Healthcare will focus on organ transplants, AI-based diagnostics, and advanced critical care. The rising demand for high-quality healthcare will support its expansion. The company’s investment in robotic surgeries, modern treatment facilities, and AI-driven diagnostics will attract Indian and international patients. These advancements will position GPT Healthcare as a leader in specialized medical services.
Our analysis shows that the share price is expected to be between Rs 1750 and Rs 2165.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2040 | 1750 | 2165 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| January | 1750 | 1820 |
| February | 1775 | 1850 |
| March | 1800 | 1880 |
| April | 1825 | 1910 |
| May | 1850 | 1940 |
| June | 1875 | 1970 |
| July | 1900 | 2000 |
| August | 1930 | 2030 |
| September | 1960 | 2060 |
| October | 1990 | 2090 |
| November | 2025 | 2130 |
| December | 2060 | 2165 |
By 2050, the company has the potential to become one of India’s top healthcare providers. The healthcare industry will transform significantly with the rise of genetic research, AI-driven diagnostics, and telemedicine. GPT Healthcare may expand internationally and collaborate with global medical firms. If it maintains financial stability, adopts the latest technology, and expands wisely, it will continue to grow and strengthen its market position.
Our analysis shows that the share price is expected to be between Rs 3065 and Rs 3375.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2050 | 3065 | 3375 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| January | 3065 | 3100 |
| February | 3090 | 3130 |
| March | 3120 | 3165 |
| April | 3150 | 3200 |
| May | 3180 | 3235 |
| June | 3205 | 3260 |
| July | 3230 | 3285 |
| August | 3255 | 3310 |
| September | 3280 | 3330 |
| October | 3300 | 3345 |
| November | 3320 | 3360 |
| December | 3350 | 3375 |
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
|---|---|---|
| 2025 | 105 | 195 |
| 2026 | 150 | 275 |
| 2030 | 750 | 1050 |
| 2040 | 1750 | 2165 |
| 2050 | 3065 | 3375 |
| Shareholder Type | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Promoters | 65.57% | 65.57% | 65.57% | 65.57% |
| FIIs | 4.71% | 4.70% | 5.38% | 6.68% |
| DIIs | 11.30% | 10.80% | 11.88% | 11.61% |
| Public | 18.41% | 18.92% | 17.16% | 16.14% |
Dr Agarwals Health Care Share Price Target 2025, 2026, 2030, 2040, 2050
Should I Buy GPT Healthcare Stock?
GPT Healthcare stock has a strong promoter holding (65.57%), meaning the owners believe in their business. FIIs are reducing stakes, which could mean big investors are cautious. DIIs and public holding are stable. If you trust the company’s growth, it’s worth considering, but check financials before buying.
GPT Healthcare Ltd Earning Results (Financials)
| Particulars | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 405 | 400 | 361 | 337 | 243 |
| Expenses | 319 | 312 | 287 | 263 | 194 |
| Operating Profit | 86 | 88 | 74 | 74 | 49 |
| OPM % | 21% | 22% | 21% | 22% | 20% |
| Other Income | 9 | 5 | 6 | 5 | 6 |
| Interest | 4 | 7 | 9 | 11 | 14 |
| Depreciation | 19 | 18 | 15 | 14 | 12 |
| Profit before tax | 71 | 68 | 56 | 54 | 29 |
| Tax % | — | 30% | 30% | 23% | 27% |
| Net Profit | 50 | 48 | 39 | 42 | 21 |
| EPS (₹) | 6.07 | 5.82 | 4.88 | 5.21 | 11.76 |
| Dividend Payout % | — | 60% | 102% | 0% | 47% |
Expert Forecasts On The Future Of GPT Healthcare Ltd.
GPT Healthcare’s financial growth is improving slowly. Sales and profit are increasing, but EPS and dividend payouts fluctuate. The stock looks stable for the future, but don’t expect very high returns. It’s good long term but not the best choice for quick profits.
Is GPT Healthcare Stock Good to Buy? (Bull case & Bear case)
Bullish Case:
- Steady growth with rising sales and profits every year.
- Strong margins with OPM around 21-22%, showing good profitability.
- Low debt as interest cost is reducing, indicating financial stability.
- Regular dividend payouts make it attractive for long-term investors.
Bearish Case:
- Fluctuating EPS, making earnings inconsistent.
- High dividend payout at times exceeds profits, which may not be sustainable.
- Slow growth compared to high-growth stocks, limiting potential returns.
- Intense competition in the healthcare sector makes future growth uncertain.
Conclusion
GPT Healthcare runs hospitals, clinics, and medical services, focusing on patient care. Growth will come from expanding hospitals, better technology, and rising healthcare demand. In the short term, stable profits and dividends will continue. New hospitals and better medical services will drive strong growth in the long term. If you’re considering an investment, you should read the full article for details about the company’s performance and future stock projections.
